Holuka Eugene Myron
SEC insider (Form 3/4/5 filer). CIK 0001678292. Director at CITIUS ONCOLOGY, INC. (CTOR) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 19, 2025. Located in CRANFORD, NJ.
Companies Holuka Eugene Myron has filed insider reports for
- CITIUS ONCOLOGY, INC. (CTOR): Director
- Citius Pharmaceuticals, Inc. (CTXR): Director
Holuka Eugene Myron
CIK: 0001678292
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 19, 2025CTOR
CITIUS ONCOLOGY, INC.
AwardDirect300K shares- - Dec 12, 2024CTOR
CITIUS ONCOLOGY, INC.
AwardDirectStock Option (Right to Buy)
125K shares- - Nov 7, 2024CTXR
Citius Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Purchase Common Stock)
125K shares-
1-3 of 3 transactions